 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
09/19/2023 |
$58.56 |
$58.92 |
$58.34 |
$58.63 |
10.46M | 09/20/2023 |
$58.80 |
$59.31 |
$58.71 |
$58.78 |
8.70M | 09/21/2023 |
$58.56 |
$59.46 |
$58.53 |
$59.08 |
9.60M | 09/22/2023 |
$59.33 |
$59.46 |
$58.77 |
$58.90 |
8.19M | 09/25/2023 |
$58.84 |
$59.28 |
$58.55 |
$59.16 |
7.01M |
 |
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. | |
 |

Bristol Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on September 19, 2023, BMY opened at $58.56, traded as high as $58.92 and as low as $58.34, and closed at $58.63. Trading volume was a total of 10.46M shares. On September 20, 2023, BMY opened at $58.80, traded as high as $59.31 and as low as $58.71, and closed at $58.78. Trading volume was a total of 8.70M shares. On September 21, 2023, BMY opened at $58.56, traded as high as $59.46 and as low as $58.53, and closed at $59.08. Trading volume was a total of 9.60M shares. On September 22, 2023, BMY opened at $59.33, traded as high as $59.46 and as low as $58.77, and closed at $58.90. Trading volume was a total of 8.19M shares. On September 25, 2023, BMY opened at $58.84, traded as high as $59.28 and as low as $58.55, and closed at $59.16. Trading volume was a total of 7.01M shares.
BMY Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
09/27/2013 |
|
End date: |
09/25/2023 |
|
Start price/share: |
$46.20 |
|
End price/share: |
$59.16 |
|
Starting shares: |
216.45 |
|
Ending shares: |
288.71 |
|
Dividends reinvested/share: |
$17.22 |
|
Total return: |
70.80% |
|
Average Annual Total Return: |
5.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$17,081.44 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/27/2013 |
|
End date: |
09/25/2023 |
|
Start price/share: |
$46.20 |
|
End price/share: |
$59.16 |
|
Dividends collected/share: |
$17.22 |
|
Total return: |
65.32% |
|
Average Annual Total Return: |
5.16% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,538.87 |
|
Years: |
10.00 |
|
|
 |
Date |
Close |
09/19/2023 | $58.63 | 09/20/2023 | $58.78 | 09/21/2023 | $59.08 | 09/22/2023 | $58.90 | 09/25/2023 | $59.16 |
|
 |